Adjusting hormones and constructing desires: new materialisations of female sexuality in Brazil

References

• Abrahamsson, S., F. Bertoni, A. Mol, and R. I. Martín. 2015. “Living with Omega–3: New Materialism and Enduring Concerns.” Environment and Planning D: Society and Space 33 (1): 4–19.
   Web of Science ®Google Scholar
• Clarke, A. E., J. Shim, L. Mamo, J. Fosket, and J. Fishman eds. 2010. Biomedicalization: Technoscience and transformations of health and illness in the U.S. Durham: Duke University Press.
   Google Scholar
• Conrad, P. 2007. Medicalization of Society: On The Transformation of Human Conditions into Treatable Disorders. Baltimore: Johns Hopkins University Press.
   Google Scholar
• Faro, L. F. T. 2016. Mulher com Bigode nem o Diabo Pode: um Estudo sobre Testosterona, Sexualidade Feminina e Niomedicalização. PhD dissertation, Federal University of Rio de Janeiro, Brazil.
   Google Scholar
• Faro, L., and J. Russo. 2017. “Testosterona, Desejo Sexual e Conflito de Interesse: Periódicos Biomédicos Como Espaços Privilegiados de Expansão Do Mercado de Medicamentos.” Horizontes Antropológicos 23 (47): 61–92.
   Google Scholar
• Fausto-Sterling, A. 2000. Sexing the Body: Gender Politics and the Construction of Sexuality. Nova York: Basic Books.
   Google Scholar
• Fausto-Sterling, A. 2015. “’Female Viagra’ is no Feminist Triumph”. Boston Review, November 23.
   Google Scholar
• Fishman, J. 2004. “Manufacturing Desire: The Commodification.” Social Studies of Science 34 (2): 187–218.
   PubMed Web of Science ®Google Scholar
• Gewirtz-Meydan, A., T. Hafford-Letchfield, L. Ayalon, Y. Benyamini, V. Biermann, A. Coffey, J. Jackson., et al. 2018. “How Do Older People Discuss Their Own Sexuality? a Systematic Review of Qualitative Research Studies.” Culture, Health & Sexuality 4: 1–16.
   PubMed Web of Science ®Google Scholar
• Giami, A., and B. Spencer. 2004. “Les Objets Techniques de la Sexualité et L‘Organisation Des Rapports de Genre Dans L‘Activité Sexuelle: Contraceptifs Oraux, Préservatifs et Traitement Des Troubles Sexuels.” Révue Epidemiologique de Santé Publique 52 (4): 377–87.
   PubMedGoogle Scholar
• Gurevich, M., U. Leedham, A. Brown-Bowers, N. Cormier, and Z. Mercer. 2017. “Propping up Pharma’s (Natural) Neoliberal Phallic Man: Pharmaceutical Representations of the Ideal Sexuopharmaceutical User.” Culture, Health & Sexuality 19 (4): 422–37.
   PubMed Web of Science ®Google Scholar
• Hoberman, J. 2005. Testosterone Dreams. Rejuvenation, Aphrodisia, Doping. Berkeley: Univ. of California Press.
   Google Scholar
• Law, J. 1999. “After ANT: Complexity, Naming and Topology”. In Actor–network theory and After., edited by Law, J., and J. Hassard, 1–14. Oxford: Blackwell.
   Google Scholar
• Law, J. 2004. After Method: Mess in Social Science Research. New York: Routledge.
   Google Scholar
• Law, J., and A. Mol. 1995. “Notes on Materiality and Sociality.” The Sociological Review 43 (2): 274–94.
   Web of Science ®Google Scholar
• Lexchin, J. 2006. “Bigger and Better: how Pfizer Redefined Erectile Dysfunction.” Plosmedicine 3 (4): 1–4.
   Google Scholar
• Loe, M. 2001. “Fixing Broken Masculinity: Viagra as a Technology for the Production of Gender and Sexuality.” Sexuality and Culture 5 (3): 97–125.
   Google Scholar
• Machado, P. S. 2008. “Intersexuality and the ‘Chicago Consensus’: The Vicissitudes of Nomenclature and Their Regulatory Implications.” Revista Brasileira de Ciências Sociais 23 (68): 109–23.
   Google Scholar
• Manica, D., and M. Nucci. 2017. “Sob a Pele: Implantes Subcutâneos, Hormônios e Gênero.” Horizontes Antropológicos 23 (47): 93–129.
   Google Scholar
• Marshall, B. 2010. “Science, Medicine and Virility Surveillance: `Sexy Seniors´ in the Pharmaceutical Imagination.” Sociology of Health & Illness 32 (2): 211–24.
   PubMed Web of Science ®Google Scholar
• Marshall, B., and S. Katz. 2002. “Forever Functional: Sexual Fitness and the Ageing Male Body.” Body & Society 8 (4): 43–70.
   Google Scholar
• Mol, A. 1999. “Ontological Politics: A Word and Some Questions”. In Actor–network theory and After., edited by J., Law, and J. Hassard, 74–89. Oxford: Blackwell.
   Google Scholar
• Mol, A. 2002. The body multiple: Ontology in medical practice. Durham: Duke University Press.
   Google Scholar
• Mol, A. 2013. “Mind Your Plate! the Ontonorms of Dutch Dieting.” Social Studies of Science 43 (3): 379–96.
   Web of Science ®Google Scholar
• Mol, A., and J. Law. 1994. “Regions, Networks and Fluids: Anaemia and Social topology.” Social Studies of Science 24 (4): 641–71.
   PubMed Web of Science ®Google Scholar
• Mol, A., and J. Law. 2004. “Embodied Action, Enacted Bodies: The Example of Hypoglycaemia”. Centre for Science Studies, Lancaster University. http://www.comp.lancs.ac.uk/sociology/papers/Mol–Law–Embodied–Action.pdf
   Google Scholar
• Moynihan, R., and B. Minstzes. 2010. Sex, Lies + Pharmaceuticals: How Drug Companies Plan to Profit From Female Sexual Dysfunction. Vancouver: Reystone.
   Google Scholar
• Oudshoorn, N. 1994. Beyond the Natural Body: an Archaeology of Sex Hormones. London: Routledge.
   Google Scholar
• Roberts, C. 2007. Messengers of Sex: Hormones, Biomedicine and Feminism. New York: Cambridge University Press.
   Google Scholar
• Rohden, F. 2008. “The Reign of Hormones and the Construction of Gender Differences.” História, Ciências, Saúde – Manguinhos 15: 133–52.
   PubMed Web of Science ®Google Scholar
• Rohden, F. 2013. “Gender Differences and the Medicalization of Sexuality in the Diagnosis of Sexual Dysfunctions”. In Sexuality, Culture And Politics: A South American Reader., edited by Sívori, H., S. Carrara, J. Russo, M. L. Heilborn, A. P. Uziel, and B. Zilli, 620–638. Rio de Janeiro: CEPESC/CLAM.
   Google Scholar
• Rohden, F. 2018. “Sexual Desire, Testosterone and Biomedical Interventions: managing Female Sexuality in ‘Ethical Doses.” Vibrant 4 (3): 1–12.
   Google Scholar
• Rohden, F. 2016. “Promotion of andropause in Brazil: a case of male medicalization”. In Diagnostic controversy: Cultural perspectives on competing knowledge in healthcare. edited by C. Smith-Morris, 79–106. New York: Routledge.
   Google Scholar
• Russo, J., F. Rohden, L. Faro, M. Nucci, and A. Giami. 2013. “Clinical Sexology in Contemporary Brazil: The Professional Dispute among Divergent Medical Views on Gender and Sexuality.” International Journal of Sexual Health 25 (1): 59–74.
   Web of Science ®Google Scholar
• Sanabria, E. 2010. “From Sub – to Super – Citizenship: Sex Hormones and the Body Politic in Brazil.” Ethnos Journal of Anthropology 75 (4): 377–401.
   Web of Science ®Google Scholar
• Shin, D. 2012. “The Landscape of Female Sexual Dysfunction Treatment”. Citeline Resource Center. Acessed 15 August 2016. http://www.citeline.com/thought-leader-blog/the-landscape-of-female-sexual-dysfunction-treatment
   Google Scholar
• Spurgas, A. 2013. “Interest, Arousal, and Shifting Diagnoses of Female Sexual Dysfunction, or: How Women Learn about Desire.” Studies in Gender and Sexuality 14 (3): 187–205.
   Google Scholar
• Tiefer, L. 2006. “Female Sexual Dysfunction: A Case Study of Disease Mongering and Activist Resistance.” Public Library of Science Medicine 3 (4): 1–5.
   Google Scholar
• Van de Port, M. 2013. “Driven by Desire”. In City of desires. A place for god?, edited by R. Ganzevoort, R. Brouwer, and B. Miller–McLemore, 19–27. Münster: LIT Verlag.
   Google Scholar
• Williams, S. J., P. Martin, and J. Gabe. 2011. “The Pharmaceuticalisation of Society? a Framework for Analysis.” Sociology of Health & Illness 33 (5): 710–25.
   PubMed Web of Science ®Google Scholar